Ad

Tag: USFDA

Drug Remdesivir is an Investigational Therapy Only

(New Delhi)Remdesivir is an Investigational Therapy
An updated Clinical Management Protocol for COVID-19 has been released by the Ministry of Health and Family Welfare on 13th June, 2020 in which the drug Remdesivir has been included as an “investigational therapy” only for restricted emergency use purposes along with off label use of Tocilizumab and Convalescent Plasma.
This drug has still not been approved (market authorization) by the US Food and Drug Administration (USFDA), where like India it continues only under an Emergency Use Authorization.